Publication | Closed Access

Effect of celecoxib on survival in patients with advanced non-small cell lung cancer: A double blind randomised clinical phase III trial (CYCLUS study) by the Swedish Lung Cancer Study Group

MedicinePathologyBronchial NeoplasmCancer TreatmentOncologyRadiation OncologyLung CancerCancer ResearchDouble BlindCyclus Study